Evaluation of clinical pharmacist recommendations in the geriatric ward of a Belgian university hospital
To evaluate the type, acceptance rate, and clinical relevance of clinical pharmacist recommendations at the geriatric ward of the Ghent university hospital. The clinical pharmacist evaluated drug use during a weekly 2-hour visit for a period of 4 months and, if needed, made recommendations to the pr...
Saved in:
Published in | Clinical interventions in aging Vol. 8; pp. 703 - 709 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
New Zealand
Dove Medical Press Limited
01.01.2013
Taylor & Francis Ltd Dove Press Dove Medical Press |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | To evaluate the type, acceptance rate, and clinical relevance of clinical pharmacist recommendations at the geriatric ward of the Ghent university hospital.
The clinical pharmacist evaluated drug use during a weekly 2-hour visit for a period of 4 months and, if needed, made recommendations to the prescribing physician. The recommendations were classified according to type, acceptance by the physician, prescribed medication, and underlying drug-related problem. Appropriateness of prescribing was assessed using the Medication Appropriateness Index (MAI) before and after the recommendations were made. Two clinical pharmacologists and two clinical pharmacists independently and retrospectively evaluated the clinical relevance of the recommendations and rated their own acceptance of them.
The clinical pharmacist recommended 304 drug therapy changes for 100 patients taking a total of 1137 drugs. The most common underlying drug-related problems concerned incorrect dose, drug-drug interaction, and adverse drug reaction, which appeared most frequently for cardiovascular drugs, drugs for the central nervous system, and drugs for the gastrointestinal tract. The most common type of recommendation concerned adapting the dose, and stopping or changing a drug. In total, 59.7% of the recommendations were accepted by the treating physician. The acceptance rate by the evaluators ranged between 92.4% and 97.0%. The mean clinical relevance of the recommendations was assessed as possibly important (53.4%), possibly low relevance (38.1%), and possibly very important (4.2%). A low interrater agreement concerning clinical relevance between the evaluators was found: kappa values ranged between 0.15 and 0.25. Summated MAI scores significantly improved after the pharmacist recommendations, with mean values decreasing from 9.3 to 6.2 (P < 0.001).
In this study, the clinical pharmacist identified a high number of potential drug-related problems in older patients; however, the acceptance of the pharmacotherapy recommendations by the treating physician was lower than by a panel of evaluators. This panel, however, rated most recommendations as possibly important and as possibly having low relevance, with low interrater reliability. As the appropriateness of prescribing seemed to improve with decreased MAI scores, clinical pharmacy services may contribute to the optimization of drug therapy in older inpatients. |
---|---|
AbstractList | To evaluate the type, acceptance rate, and clinical relevance of clinical pharmacist recommendations at the geriatric ward of the Ghent university hospital.
The clinical pharmacist evaluated drug use during a weekly 2-hour visit for a period of 4 months and, if needed, made recommendations to the prescribing physician. The recommendations were classified according to type, acceptance by the physician, prescribed medication, and underlying drug-related problem. Appropriateness of prescribing was assessed using the Medication Appropriateness Index (MAI) before and after the recommendations were made. Two clinical pharmacologists and two clinical pharmacists independently and retrospectively evaluated the clinical relevance of the recommendations and rated their own acceptance of them.
The clinical pharmacist recommended 304 drug therapy changes for 100 patients taking a total of 1137 drugs. The most common underlying drug-related problems concerned incorrect dose, drug-drug interaction, and adverse drug reaction, which appeared most frequently for cardiovascular drugs, drugs for the central nervous system, and drugs for the gastrointestinal tract. The most common type of recommendation concerned adapting the dose, and stopping or changing a drug. In total, 59.7% of the recommendations were accepted by the treating physician. The acceptance rate by the evaluators ranged between 92.4% and 97.0%. The mean clinical relevance of the recommendations was assessed as possibly important (53.4%), possibly low relevance (38.1%), and possibly very important (4.2%). A low interrater agreement concerning clinical relevance between the evaluators was found: kappa values ranged between 0.15 and 0.25. Summated MAI scores significantly improved after the pharmacist recommendations, with mean values decreasing from 9.3 to 6.2 (P < 0.001).
In this study, the clinical pharmacist identified a high number of potential drug-related problems in older patients; however, the acceptance of the pharmacotherapy recommendations by the treating physician was lower than by a panel of evaluators. This panel, however, rated most recommendations as possibly important and as possibly having low relevance, with low interrater reliability. As the appropriateness of prescribing seemed to improve with decreased MAI scores, clinical pharmacy services may contribute to the optimization of drug therapy in older inpatients. Objective: To evaluate the type, acceptance rate, and clinical relevance of clinical pharmacist recommendations at the geriatric ward of the Ghent university hospital. Methods: The clinical pharmacist evaluated drug use during a weekly 2-hour visit for a period of 4 months and, if needed, made recommendations to the prescribing physician. The recommendations were classified according to type, acceptance by the physician, prescribed medication, and underlying drug-related problem. Appropriateness of prescribing was assessed using the Medication Appropriateness Index (MAI) before and after the recommendations were made. Two clinical pharmacologists and two clinical pharmacists independently and retrospectively evaluated the clinical relevance of the recommendations and rated their own acceptance of them. Results: The clinical pharmacist recommended 304 drug therapy changes for 100 patients taking a total of 1137 drugs. The most common underlying drug-related problems concerned incorrect dose, drug-drug interaction, and adverse drug reaction, which appeared most frequently for cardiovascular drugs, drugs for the central nervous system, and drugs for the gastrointestinal tract. The most common type of recommendation concerned adapting the dose, and stopping or changing a drug. In total, 59.7% of the recommendations were accepted by the treating physician. The acceptance rate by the evaluators ranged between 92.4% and 97.0%. The mean clinical relevance of the recommendations was assessed as possibly important (53.4%), possibly low relevance (38.1%), and possibly very important (4.2%). A low interrater agreement concerning clinical relevance between the evaluators was found: kappa values ranged between 0.15 and 0.25. Summated MAI scores significantly improved after the pharmacist recommendations, with mean values decreasing from 9.3 to 6.2 (P < 0.001). Conclusion: In this study, the clinical pharmacist identified a high number of potential drug-related problems in older patients; however, the acceptance of the pharmacotherapy recommendations by the treating physician was lower than by a panel of evaluators. This panel, however, rated most recommendations as possibly important and as possibly having low relevance, with low interrater reliability. As the appropriateness of prescribing seemed to improve with decreased MAI scores, clinical pharmacy services may contribute to the optimization of drug therapy in older inpatients. Keywords: clinical pharmacist, drug-related problems, geriatric inpatients Annemie Somers,1 Hugo Robays,1 Peter De Paepe,2 Georges Van Maele,3 Katrina Perehudoff,4 Mirko Petrovic41Department of Pharmacy, Ghent University Hospital, Ghent, Belgium; 2Department of Emergency Medicine, Ghent University Hospital, Ghent, Belgium; 3Department of Medical Statistics, Ghent University Hospital, Ghent, Belgium; 4Department of Geriatrics, Ghent University Hospital, Ghent, BelgiumObjective: To evaluate the type, acceptance rate, and clinical relevance of clinical pharmacist recommendations at the geriatric ward of the Ghent university hospital.Methods: The clinical pharmacist evaluated drug use during a weekly 2-hour visit for a period of 4 months and, if needed, made recommendations to the prescribing physician. The recommendations were classified according to type, acceptance by the physician, prescribed medication, and underlying drug-related problem. Appropriateness of prescribing was assessed using the Medication Appropriateness Index (MAI) before and after the recommendations were made. Two clinical pharmacologists and two clinical pharmacists independently and retrospectively evaluated the clinical relevance of the recommendations and rated their own acceptance of them.Results: The clinical pharmacist recommended 304 drug therapy changes for 100 patients taking a total of 1137 drugs. The most common underlying drug-related problems concerned incorrect dose, drug-drug interaction, and adverse drug reaction, which appeared most frequently for cardiovascular drugs, drugs for the central nervous system, and drugs for the gastrointestinal tract. The most common type of recommendation concerned adapting the dose, and stopping or changing a drug. In total, 59.7% of the recommendations were accepted by the treating physician. The acceptance rate by the evaluators ranged between 92.4% and 97.0%. The mean clinical relevance of the recommendations was assessed as possibly important (53.4%), possibly low relevance (38.1%), and possibly very important (4.2%). A low interrater agreement concerning clinical relevance between the evaluators was found: kappa values ranged between 0.15 and 0.25. Summated MAI scores significantly improved after the pharmacist recommendations, with mean values decreasing from 9.3 to 6.2 (P < 0.001).Conclusion: In this study, the clinical pharmacist identified a high number of potential drug-related problems in older patients; however, the acceptance of the pharmacotherapy recommendations by the treating physician was lower than by a panel of evaluators. This panel, however, rated most recommendations as possibly important and as possibly having low relevance, with low interrater reliability. As the appropriateness of prescribing seemed to improve with decreased MAI scores, clinical pharmacy services may contribute to the optimization of drug therapy in older inpatients.Keywords: clinical pharmacist, drug-related problems, geriatric inpatients To evaluate the type, acceptance rate, and clinical relevance of clinical pharmacist recommendations at the geriatric ward of the Ghent university hospital.Methods: The clinical pharmacist evaluated drug use during a weekly 2-hour visit for a period of 4 months and, if needed, made recommendations to the prescribing physician. The recommendations were classified according to type, acceptance by the physician, prescribed medication, and underlying drug-related problem. Appropriateness of prescribing was assessed using the Medication Appropriateness Index (MAI) before and after the recommendations were made. Two clinical pharmacologists and two clinical pharmacists independently and retrospectively evaluated the clinical relevance of the recommendations and rated their own acceptance of them.Results: The clinical pharmacist recommended 304 drug therapy changes for 100 patients taking a total of 1137 drugs. The most common underlying drug-related problems concerned incorrect dose, drug-drug interaction, and adverse drug reaction, which appeared most frequently for cardiovascular drugs, drugs for the central nervous system, and drugs for the gastrointestinal tract. The most common type of recommendation concerned adapting the dose, and stopping or changing a drug. In total, 59.7% of the recommendations were accepted by the treating physician. The acceptance rate by the evaluators ranged between 92.4% and 97.0%. The mean clinical relevance of the recommendations was assessed as possibly important (53.4%), possibly low relevance (38.1%), and possibly very important (4.2%). A low interrater agreement concerning clinical relevance between the evaluators was found: kappa values ranged between 0.15 and 0.25. Summated MAI scores significantly improved after the pharmacist recommendations, with mean values decreasing from 9.3 to 6.2 (P < 0.001).Conclusion: In this study, the clinical pharmacist identified a high number of potential drug-related problems in older patients; however, the acceptance of the pharmacotherapy recommendations by the treating physician was lower than by a panel of evaluators. This panel, however, rated most recommendations as possibly important and as possibly having low relevance, with low interrater reliability. As the appropriateness of prescribing seemed to improve with decreased MAI scores, clinical pharmacy services may contribute to the optimization of drug therapy in older inpatients. Objective: To evaluate the type, acceptance rate, and clinical relevance of clinical pharmacist recommendations at the geriatric ward of the Ghent university hospital. Methods: The clinical pharmacist evaluated drug use during a weekly 2-hour visit for a period of 4 months and, if needed, made recommendations to the prescribing physician. The recommendations were classified according to type, acceptance by the physician, prescribed medication, and underlying drug-related problem. Appropriateness of prescribing was assessed using the Medication Appropriateness Index (MAI) before and after the recommendations were made. Two clinical pharmacologists and two clinical pharmacists independently and retrospectively evaluated the clinical relevance of the recommendations and rated their own acceptance of them. Results: The clinical pharmacist recommended 304 drug therapy changes for 100 patients taking a total of 1137 drugs. The most common underlying drug-related problems concerned incorrect dose, drug–drug interaction, and adverse drug reaction, which appeared most frequently for cardiovascular drugs, drugs for the central nervous system, and drugs for the gastrointestinal tract. The most common type of recommendation concerned adapting the dose, and stopping or changing a drug. In total, 59.7% of the recommendations were accepted by the treating physician. The acceptance rate by the evaluators ranged between 92.4% and 97.0%. The mean clinical relevance of the recommendations was assessed as possibly important (53.4%), possibly low relevance (38.1%), and possibly very important (4.2%). A low interrater agreement concerning clinical relevance between the evaluators was found: kappa values ranged between 0.15 and 0.25. Summated MAI scores significantly improved after the pharmacist recommendations, with mean values decreasing from 9.3 to 6.2 (P < 0.001). Conclusion: In this study, the clinical pharmacist identified a high number of potential drug-related problems in older patients; however, the acceptance of the pharmacotherapy recommendations by the treating physician was lower than by a panel of evaluators. This panel, however, rated most recommendations as possibly important and as possibly having low relevance, with low interrater reliability. As the appropriateness of prescribing seemed to improve with decreased MAI scores, clinical pharmacy services may contribute to the optimization of drug therapy in older inpatients. |
Audience | Academic |
Author | Petrovic, Mirko De Paepe, Peter Perehudoff, Katrina Van Maele, Georges Robays, Hugo Somers, Annemie |
AuthorAffiliation | 4 Department of Geriatrics, Ghent University Hospital, Ghent, Belgium 2 Department of Emergency Medicine, Ghent University Hospital, Ghent, Belgium 3 Department of Medical Statistics, Ghent University Hospital, Ghent, Belgium 1 Department of Pharmacy, Ghent University Hospital, Ghent, Belgium |
AuthorAffiliation_xml | – name: 1 Department of Pharmacy, Ghent University Hospital, Ghent, Belgium – name: 2 Department of Emergency Medicine, Ghent University Hospital, Ghent, Belgium – name: 3 Department of Medical Statistics, Ghent University Hospital, Ghent, Belgium – name: 4 Department of Geriatrics, Ghent University Hospital, Ghent, Belgium |
Author_xml | – sequence: 1 givenname: Annemie surname: Somers fullname: Somers, Annemie email: annemie.somers@uzgent.be organization: Department of Pharmacy, Ghent University Hospital, Ghent, Belgium. annemie.somers@uzgent.be – sequence: 2 givenname: Hugo surname: Robays fullname: Robays, Hugo – sequence: 3 givenname: Peter surname: De Paepe fullname: De Paepe, Peter – sequence: 4 givenname: Georges surname: Van Maele fullname: Van Maele, Georges – sequence: 5 givenname: Katrina surname: Perehudoff fullname: Perehudoff, Katrina – sequence: 6 givenname: Mirko surname: Petrovic fullname: Petrovic, Mirko |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23807844$$D View this record in MEDLINE/PubMed |
BookMark | eNptUluLEzEYHWTFveiLP0AGBB-E1lxmMpkXoZZVCws-qM8hk3zppMwkNcl02X9vtt0urZg8JHw553yXnOviwnkHRfEWoznBVfNpuVrMf1YEM_KiuMK44TPctvzi5H5ZXMe4QahmTU1eFZeEctTwqroq-tudHCaZrHelN6UarLNKDuW2l2GUysZUBlB-HMHpPSqW1pWph3INwcoUrCrvZdCPZFl-gWFtpSsnZ3cQok0PZe_j1iY5vC5eGjlEePN03hS_v97-Wn6f3f34tlou7maKYZxmuq4xJ0CMhhbprmoMQ5q0Jr-qCjqJoNOKa82x0W1dUwWKMU6UMYojXVN6U6wOutrLjdgGO8rwILy0Yh_wYS1kSFYNIBoCXKNaI9S2FdFNJ1WtGmaAc0OZarLW54PWdupG0ApcCnI4Ez1_cbYXa78TlHFGqjoLoGMxO9gGiPGfio7RPGGBKaUoU94_5Qz-zwQxiY2fgssjEyQvXJOKnKDWMjdinfE5vxptVGJBm4pjwvbp5_9B5a1htCqbyNgcPyN8OCH0IIfURz9M-48_B348AFXwMQYwz31hJB5NKbIpxcGUGfzudIzP0KML6V-0X-Ad |
CitedBy_id | crossref_primary_10_1080_17843286_2019_1568353 crossref_primary_10_1186_s12913_021_06966_4 crossref_primary_10_1007_s40267_018_0516_0 crossref_primary_10_1007_s40267_017_0468_9 crossref_primary_10_3390_pharmacy8010014 crossref_primary_10_1016_j_sapharm_2019_10_014 crossref_primary_10_1007_s11096_021_01302_6 crossref_primary_10_1080_17843286_2020_1864162 crossref_primary_10_1038_s41598_022_15657_x crossref_primary_10_1093_ageing_afaa062 crossref_primary_10_18553_jmcp_2018_24_12_1250 crossref_primary_10_1111_jgs_15177 crossref_primary_10_24304_kjcp_2019_29_3_193 crossref_primary_10_1016_j_sapharm_2017_02_015 crossref_primary_10_1016_j_dsx_2015_09_017 crossref_primary_10_3390_pharmacy5020031 crossref_primary_10_1016_j_sapharm_2019_10_002 crossref_primary_10_1186_s12877_023_04591_w crossref_primary_10_1590_1518_8345_1316_2800 crossref_primary_10_1007_s11096_017_0572_x crossref_primary_10_1093_ageing_afaa175 crossref_primary_10_1177_10781552211066959 crossref_primary_10_1186_s13584_019_0285_9 crossref_primary_10_1111_jep_14010 crossref_primary_10_1007_s11096_019_00936_x crossref_primary_10_23736_S1824_4777_22_01534_0 crossref_primary_10_1371_journal_pone_0218174 crossref_primary_10_1016_j_phclin_2020_09_007 crossref_primary_10_1002_jppr_1539 crossref_primary_10_1016_j_pharma_2018_01_002 crossref_primary_10_1186_s40780_021_00232_9 crossref_primary_10_1136_ejhpharm_2014_000491 crossref_primary_10_1007_s40264_015_0370_0 crossref_primary_10_1155_2022_8742998 crossref_primary_10_1111_jcpt_13091 crossref_primary_10_1186_s12913_019_3942_3 crossref_primary_10_1007_s11096_018_0643_7 crossref_primary_10_1007_s11096_014_9957_2 crossref_primary_10_1136_ejhpharm_2023_003840 crossref_primary_10_1016_j_rcsop_2024_100427 crossref_primary_10_1007_s40266_016_0356_3 crossref_primary_10_1016_j_sapharm_2021_05_003 crossref_primary_10_1590_1981_22562018021_180085 crossref_primary_10_3390_medicina56070320 crossref_primary_10_1016_j_imu_2022_101015 crossref_primary_10_1111_jcpt_13017 crossref_primary_10_1177_2042098619843365 crossref_primary_10_5937_opmed0_48159 crossref_primary_10_1007_s11096_017_0513_8 crossref_primary_10_3390_ijerph20010766 crossref_primary_10_1007_s11096_022_01526_0 crossref_primary_10_1007_s11096_017_0530_7 crossref_primary_10_1080_17843286_2019_1683128 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2013 Dove Medical Press Limited 2013. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2013 Somers et al, publisher and licensee Dove Medical Press Ltd. 2013 |
Copyright_xml | – notice: COPYRIGHT 2013 Dove Medical Press Limited – notice: 2013. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2013 Somers et al, publisher and licensee Dove Medical Press Ltd. 2013 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7RV 7XB 8C1 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH KB0 M2O MBDVC NAPCQ PIMPY PQEST PQQKQ PQUKI PRINS Q9U 5PM DOA |
DOI | 10.2147/CIA.S42162 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Nursing & Allied Health Database ProQuest Central (purchase pre-March 2016) Public Health Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep Nursing & Allied Health Database (Alumni Edition) Research Library Research Library (Corporate) Nursing & Allied Health Premium Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic PubMed Central (Full Participant titles) Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Publicly Available Content Database ProQuest Public Health Research Library Prep ProQuest Central Student ProQuest Central Basic ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Research Library (Alumni Edition) Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central Nursing & Allied Health Premium Health Research Premium Collection ProQuest One Academic UKI Edition ProQuest Central Korea ProQuest Research Library ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest Central (Alumni) |
DatabaseTitleList | MEDLINE Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Public Health |
EISSN | 1178-1998 |
EndPage | 709 |
ExternalDocumentID | oai_doaj_org_article_72e8d05d009942d7bac5c76fe88f36c7 oai_dovepress_com_13330 A374812645 10_2147_CIA_S42162 23807844 |
Genre | Evaluation Studies Journal Article |
GeographicLocations | Belgium |
GeographicLocations_xml | – name: Belgium |
GroupedDBID | --- 0YH 29B 2WC 53G 5GY 5VS 7RV 8C1 8FI 8FJ 8G5 ABUWG ADBBV ADRAZ AENEX AFKRA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BCNDV BENPR BKEYQ BPHCQ BVXVI C1A CCPQU CGR CS3 CUY CVF DIK DU5 DWQXO E3Z EBS ECM EIF EJD EMOBN F5P FYUFA GNUQQ GROUPED_DOAJ GUQSH GX1 HYE IAO IHR IHW IPNFZ ITC KQ8 M2O M48 M~E NAPCQ NPM O5R O5S OK1 P2P PGMZT PIMPY PQQKQ PROAC RIG RNS RPM TR2 UKHRP VDV AAYXX CITATION TDBHL 3V. 7XB 8FK MBDVC PQEST PQUKI PRINS Q9U - ADACO AGCAB BBAFP LI0 5PM |
ID | FETCH-LOGICAL-c611t-d55182e2fde90db47f60d29fc61c4eba0ebdc8dd81fd9553cec6682cffc80d533 |
IEDL.DBID | RPM |
ISSN | 1178-1998 1176-9092 |
IngestDate | Fri Oct 04 13:09:07 EDT 2024 Tue Sep 17 21:18:55 EDT 2024 Mon Jan 18 10:57:42 EST 2021 Thu Oct 10 15:43:51 EDT 2024 Thu Feb 22 23:51:25 EST 2024 Wed Oct 25 09:32:28 EDT 2023 Tue Aug 20 22:12:43 EDT 2024 Thu Sep 26 19:43:48 EDT 2024 Sat Sep 28 08:00:47 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | geriatric inpatients clinical pharmacist drug-related problems |
Language | English |
License | This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c611t-d55182e2fde90db47f60d29fc61c4eba0ebdc8dd81fd9553cec6682cffc80d533 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3686245/ |
PMID | 23807844 |
PQID | 2222152420 |
PQPubID | 3933186 |
PageCount | 7 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_72e8d05d009942d7bac5c76fe88f36c7 pubmedcentral_primary_oai_pubmedcentral_nih_gov_3686245 dovepress_primary_oai_dovepress_com_13330 proquest_journals_2222152420 gale_infotracmisc_A374812645 gale_infotracacademiconefile_A374812645 gale_healthsolutions_A374812645 crossref_primary_10_2147_CIA_S42162 pubmed_primary_23807844 |
PublicationCentury | 2000 |
PublicationDate | 2013-01-01 |
PublicationDateYYYYMMDD | 2013-01-01 |
PublicationDate_xml | – month: 01 year: 2013 text: 2013-01-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | New Zealand |
PublicationPlace_xml | – name: New Zealand – name: Auckland |
PublicationTitle | Clinical interventions in aging |
PublicationTitleAlternate | Clin Interv Aging |
PublicationYear | 2013 |
Publisher | Dove Medical Press Limited Taylor & Francis Ltd Dove Press Dove Medical Press |
Publisher_xml | – name: Dove Medical Press Limited – name: Taylor & Francis Ltd – name: Dove Press – name: Dove Medical Press |
References | 14742785 - Ann Pharmacother. 2004 Jan;38(1):9-14 20396637 - Clin Interv Aging. 2010;5:75-87 1474400 - J Clin Epidemiol. 1992 Oct;45(10):1045-51 10422996 - JAMA. 1999 Jul 21;282(3):267-70 10595804 - Am J Health Syst Pharm. 1999 Dec 1;56(23):2444-50 18947262 - Drugs Aging. 2008;25(11):947-54 17592752 - Pharm World Sci. 2008 Jan;30(1):31-8 20617292 - J Nutr Health Aging. 2010 Jun;14(6):477-82 14504113 - Arch Intern Med. 2003 Sep 22;163(17):2014-8 2316538 - Am J Hosp Pharm. 1990 Mar;47(3):533-43 16682568 - Arch Intern Med. 2006 May 8;166(9):955-64 15665005 - BMJ. 2005 Feb 5;330(7486):293 12610749 - Eur J Clin Pharmacol. 2003 Feb;58(10):707-14 16569792 - Ann Pharmacother. 2006 Apr;40(4):720-8 19433702 - Arch Intern Med. 2009 May 11;169(9):894-900 11213848 - Pharmacotherapy. 2001 Feb;21(2):129-41 15521898 - Br J Clin Pharmacol. 2004 Nov;58(5):503-11 16553481 - Consult Pharm. 2004 May;19(5):432-6 17493184 - J Am Geriatr Soc. 2007 May;55(5):658-65 |
References_xml | |
SSID | ssj0056752 |
Score | 2.2569838 |
Snippet | To evaluate the type, acceptance rate, and clinical relevance of clinical pharmacist recommendations at the geriatric ward of the Ghent university hospital.... Objective: To evaluate the type, acceptance rate, and clinical relevance of clinical pharmacist recommendations at the geriatric ward of the Ghent university... To evaluate the type, acceptance rate, and clinical relevance of clinical pharmacist recommendations at the geriatric ward of the Ghent university... Annemie Somers,1 Hugo Robays,1 Peter De Paepe,2 Georges Van Maele,3 Katrina Perehudoff,4 Mirko Petrovic41Department of Pharmacy, Ghent University Hospital,... |
SourceID | doaj pubmedcentral dovepress proquest gale crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 703 |
SubjectTerms | Aged, 80 and over Belgium Clinical pharmacist Drug dosages Drug Interactions drug related problems Drug stores Drug therapy Drug Utilization Review Evaluation Female geriatric inpatients Geriatrics Geriatrics - standards Hospitals, University Humans Inappropriate Prescribing Inpatients Male Original Research Pharmaceutical Services - standards Pharmacists Pharmacists - standards Pharmacy Practice Prescription drugs Quality Indicators, Health Care Retrospective Studies Statistics, Nonparametric |
SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB6hHngIISiv0BYsgYQ4hCaOXzluq1YFCS5QqTcr8aNbiWYruuX3MxMn0aYcuFTavcSzq9gz9nyTzHwD8KE1BmG6UDm6Wp4LHeu8DaXP0VkgvOeO2HEp2-K7OjkVX8_k2UarL8oJS_TAaeH2NQ_GF9ITlBHc67Zx0mkVgzGxUi7VkZdyDKbSGSwRBvPUVsVQKoVJxKTUk2f_8Mvi8w_BS8Vnrqhn7H8ED_zqT0pB_feM3nBS8wTKDY90_BSeDFCSLdIUnsG90G3D_W_Dy_JteJweybFUafQclkcTszdbRTbWRLKrxF6N-mYUHl9ehqHR0jW76BgCRHZOZkpU_oxybOnHDTsIv87RtNjNlNnBlkMPkhdwenz08_AkHxot5E6V5Tr3RMvGA48-1IVvUWOq8LyOOOpEaJsitN4Z700ZfS1l5YJTynAXozOFR8D4Era6VRdeA4t1gx8tA_oAoQ2KV03ptMdADb-FzuD9uOb2KvFpWIxDSDMWNWOTZjI4IHVMEsSB3V9Ay7CDZdj_WUYGnyZl3vqn8SquqcUgvSoyeEfKtqn4dNr1dkHsPCWCRpnBx16C9j3q3DVD-QJOmxi0ZpK7M0ncr24-PBqUHc6La4sojRoMC4538irZ1nTLvO8JIEQGemZ1sznNR7qLZc8UXvX1P_LNXSznDjzkfSsQevy0C1vr3zdhDwHZun3b772_elo0YA priority: 102 providerName: Directory of Open Access Journals – databaseName: Public Health Database dbid: 8C1 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB5BkXgIISivQAFLICEOaRPHcZwT2q5aFSS4QKXerMSP3Up0s3S3_H5mYic0ICHtXuLZzWNmPGNn5vsA3rVKYZouZIqhlqei8nXautymGCwwveeG0HGp2uKrPDkVn8_Ks7jhtolllcOc2E_UtjO0R36AcYwoWAXPPq5_psQaRW9XI4XGTbiVo2ESdYOajyUeJSbDPJCryLTOah7gSYmZ52D-abb_TfBc8klA6nH778Ed2_0Khaj_ztTXQtW0jPJaXDp-CA9iQslmwQIewQ232oXbX-Ir8124HzbmWOg3egzLoxHfm3WeDZ2RbB0wrFHrjBbJFxcu0i1t2PmKYZrIFmSsBOjPqNKWftywQ_djgQbGrsb6DraMTCRP4PT46Pv8JI10C6mReb5NLYGzcce9dXVmW9SbzCyvPY4a4domc601ylqVe1uXZWGckVJx471RmcW08SnsrLqVew7M1w1-qtJhJBCVQvGiyU1lcbmG36xK4O3wzPU6oGpoXI2QZjRqRgfNJHBI6hglCAm7P9BdLnR0LF1xp2xWWkp1BbdV25jSVNI7pXwhDZ7qw6jMv_5pOIrPVONSvcgSeEPK1qEFdfR9PSOMnhxTxzKB970EeT_q3DSxiQFvm3C0JpJ7E0n0WjMdHgxKx1ljo__YeALPgm2Nl8x7ZgAhEqgmVje5p-nI6nzZ44UXfRdQ-eL_p3wJd3lP9UHbS3uws728cq8w4dq2r3uv-g3jnis1 priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3da9RAEB9KBT-QovUrtuqCgviQNtlsspuHUq6lpQr1RQ_6tiT7cVdoc_V6Ff3vnckmoak-Cncv2cldsjO785tk5jcAH2qlEKaLIkZXy2MhfRnXLrUxOguE99wQOy5lW3wtTqbiy1l-tgZ9_85uAq__GdpRP6np8mLn14_f-7jg9yiNORVy9_DzZOeb4Cltxfe4yARZ-qkY3ibkCIp5aLKiKLFCBZrSO-eOHFPL3_8IHtjFz5CQ-veOfctljdMpb_mn4yew0QFLNgmW8BTWXLMJ90-7V-eb8Dg8oGOh7ugZzI8Gnm-28KyvkGRXgcsatc8oWL68dF3bpWt23jCEi2xGRkvE_owybunkih24ixkaGrsZ8jzYvOtI8hymx0ffD0_iru1CbIo0XcWWSNq44966MrE16q9ILC89jhrh6ipxtTXKWpV6W-Z5ZpwpCsWN90YlFuHjC1hvFo17BcyXFX5k7tAjCKlQPKtSIy2GbfhNZATv-znXV4FdQ2NUQprRqBkdNBPBAaljkCBG7PbAYjnT3QLTkjtlk9wS5BXcyroyuZGFd0r5rDD4V58GZd75pf4ozqnGkD1LInhHytahFHXYA_SEuHpShJB5BB9bCbJL1LmpumIGvG3i0xpJbo8kcfWa8XBvULo3fo2YjdoNC45X8jLY1nDJvO0QIEQEcmR1o3sajzTn85Y3PGurgfLX_2M6t-AhbxuD0MOobVhfLW_cG4Rnq_ptu_b-AIH7OnA priority: 102 providerName: Scholars Portal |
Title | Evaluation of clinical pharmacist recommendations in the geriatric ward of a Belgian university hospital |
URI | https://www.ncbi.nlm.nih.gov/pubmed/23807844 https://www.proquest.com/docview/2222152420 http://www.dovepress.com/getfile.php?fileID=16387 https://pubmed.ncbi.nlm.nih.gov/PMC3686245 https://doaj.org/article/72e8d05d009942d7bac5c76fe88f36c7 |
Volume | 8 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Rb9MwED6tQwImhGAMKIxiCSTEQ9rEcRznsa06BlKnCZjUNyuxnbbSmlZbt9_P2U6iBd6Q2j7Yl9bJ3fnu3LvvAD4XQqCbzniAppYGLC2zoDCRDtBYoHtPlUXHtdkWF_z8iv1YJIsDSJpaGJe0r4r1sLreDKv1yuVW7jZq1OSJjS7n09iVNSSjHvTSOG5CdL_9JugBU99RhQdZmFGPSWrb8Yym38fDX4xG3PawoQ5qnbGOQXK4_UfwRG_vfSLqvzv1A1PVTaN8YJfOXsDz2qEkY7_wl3BgqmN4PK__Mj-GZ_5gjvh6o1ewmrX43mRbkqYykuw8hjVyndggebMxdbulW7KuCLqJZGmF1QL6E5tpay_OycRcL1HAyF2b30FWdSeSE7g6m_2engd1u4VA8SjaB9qCs1FDS22yUBfINx5qmpU4q5gp8tAUWgmtRVTqLEliZRTngqqyVCLU6Da-hsNqW5m3QMosx1eaGLQELBVIHueRSjWGa_gO0z58ap653HlUDYnRiGWSRCZJz6Q-TCw7WgqLhO0GtjdLWcuDTKkROky0dXUZ1WmRq0SlvDRClDFX-FNfW2b-9U3NKD5TiaF6HPbho2W29CWore7LscXoidB1TPrwxVFY7Ueeq7wuYsDbtjhaHcrTDiVqrepONwIl613jVqKvZtsMM4oreeNlq11yI659SDtS17mn7gyqj8MLr9Xl3X9f-R6eUtcFxJ48ncLh_ubOfEBfbF8MoCem0QAeTWYXlz8H7kQDP78tcKw3Z2LgdPMP6wk5vw |
link.rule.ids | 230,315,733,786,790,870,891,2115,12250,21416,24346,27955,27956,33299,33777,43612,43838,53825,53827,74369,74657 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bb9MwFD6CTmIghGDcAoNZAgnxkC1xbs4TaqdOHWwVgk3am5XYTjuJJWXt-P2cEzthAQmpfYlPm8u52jn-PoD3pRBYpsepj6mW-3FW5X5pQu1jssDynitCx6Vui3k6O48_XyQXbsFt7doqu5jYBmrdKFojP8A8RhSsMQ8-rX76xBpFb1cdhcZd2CLITTGCrcl0_vVbF4sTLIe5pVdJ_TzIuQUoJW6eg8Pj8f73mIcpH6SkFrn_AWzr5pdtRf03Vt9KVsNGyluZ6egxPHIlJRtbG3gCd0y9A_dO3UvzHXhol-aY3XH0FJbTHuGbNRXr9kaylUWxRr0zmiZfXRlHuLRmlzXDQpEtyFwJ0p9Rry39uGAT82OBJsZu-g4PtnRcJM_g_Gh6djjzHeGCr9Iw3Pia4Nm44ZU2eaBL1FwaaJ5XOKpiUxaBKbUSWouw0nmSRMqoNBVcVZUSgcbC8TmM6qY2L4FVeYGfLDGYC-JMoHhUhCrTOGHDb5B58K575nJlcTUkzkdIMxI1I61mPJiQOnoJwsJuDzTXC-lcS2bcCB0kmordmOusLFSisrQyQlRRqvBUH3tl_vVP3VF8phIn61HgwR4pW9pNqL33yzGh9IRYPCYefGglyP9R56pw2xjwtglJayC5O5BEv1XD4c6gpIsba_nHyj14YW2rv2TecgPEsQfZwOoG9zQcqS-XLWJ41O4DSl79_5R7sD07Oz2RJ8fzL6_hPm-JP2ixaRdGm-sb8wbLr0351vnYb6IfL8k |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Zb9NAEB5BKxUQQlAuQ6ErgYR4MLE367X9hNKSqOWIKqBS31b2HkklmoQm5fcz412bGiSk5MU7iY-ZnWM9-30Ar-uiwDRdyBhDLY9F7sq4tqmJMVhges81oeNSt8VUHp2Kj2fZWeh_Woe2ytYnNo7aLDWtkQ8wjhEFq-DJwIW2iJMPk_ernzExSNGb1kCncRO2cyEzLMS2D8bTk6-tX84wNeaeakXGZVJyD1ZKPD2Dw-PRu2-Cp5L3wlOD4n8HbpnlL9-W-q_fvha4-k2V16LU5D7cC-klG3l7eAA37GIXdr6EF-i7cNcv0zG_--ghzMcd2jdbOtbuk2Qrj2iNNsCoZL64sIF8ac3OFwyTRjYj0yV4f0Z9t_Tjih3YHzM0N3bVdXuweeAleQSnk_H3w6M4kC_EWqbpJjYE1cYtd8aWialRizIxvHQ4qoWtq8TWRhfGFKkzZZYNtdVSFlw7p4vEYBL5GLYWy4V9CsyVFX7yzGJcEHmB4sMq1bnB4g2_SR7Bq_aZq5XH2FBYm5BmFGpGec1EcEDq6CQIF7s5sLycqTDNVM5tYZLMUOIruMnrSmc6l84WhRtKjad62ynzr39qj-IzVVi4D5MI9knZym9I7TyBGhFiT4qJZBbBm0aCfAHqXFdhSwPeNqFq9ST3epI4h3V_uDUoFXzIWv2x-AieeNvqLpk3PAFCRJD3rK53T_2Rxfm8QQ8fNnuCsmf_P-U-7OD0Up-Pp5-ew23ecIDQutMebG0ur-wLzMQ29cswxX4D20oz_Q |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evaluation+of+clinical+pharmacist+recommendations+in+the+geriatric+ward+of+a+Belgian+university+hospital&rft.jtitle=Clinical+interventions+in+aging&rft.au=Somers+A&rft.au=Robays+H&rft.au=De+Paepe+P&rft.au=Van+Maele+G&rft.date=2013-01-01&rft.pub=Dove+Medical+Press&rft.issn=1178-1998&rft.volume=8&rft.spage=703&rft.epage=709&rft_id=info:doi/10.2147%2FCIA.S42162&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_72e8d05d009942d7bac5c76fe88f36c7 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1178-1998&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1178-1998&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1178-1998&client=summon |